Guillain-Barré syndrome after COVID-19 vaccination: report of two cases from Vietnam

J Infect Dev Ctries. 2022 Nov 29;16(11):1703-1705. doi: 10.3855/jidc.16998.

Abstract

Coronavirus disease 2019 (COVID-19) was declared a pandemic by the World Health Organization in March 2020 and since then it has spread to almost every country around the world. Vaccines against COVID-19 are considered an essential measure to curb this pandemic. However, side effects, including local and systemic reactions, after administering the COVID-19 vaccine have been defined, and some side effects have been reported. We present two cases of Guillain-Barré Syndrome (GBS) after receiving the ChAdOx1 nCoV-19 vaccine (Oxford- AstraZeneca). Both cases were admitted to the 108 Military Central Hospital, Vietnam, and received plasmapheresis therapy with satisfactory recovery after treatment.

Keywords: COVID-19; GBS; Guillain-Barré syndrome; plasmapheresis; vaccination.

Publication types

  • Case Reports

MeSH terms

  • COVID-19 Vaccines / adverse effects
  • COVID-19*
  • ChAdOx1 nCoV-19
  • Guillain-Barre Syndrome* / diagnosis
  • Guillain-Barre Syndrome* / etiology
  • Humans
  • Vaccination
  • Vietnam

Substances

  • COVID-19 Vaccines
  • ChAdOx1 nCoV-19